Feifei Na
Impact in
- Oncology top 10%
- Cancer Immunotherapy and Biomarkers
- Lung Cancer Research Studies
- Cancer Cells and Metastasis
-
- Lung Cancer Diagnosis and Treatment
Papers in
- Oncology 18
- Cancer Immunotherapy and Biomarkers 11
- Lung Cancer Research Studies 7
-
- Lung Cancer Diagnosis and Treatment 5
- Lung Cancer Treatments and Mutations 3
- Co-authors
- Jianxin Xue (13 shared papers)You Lü (9 shared papers)Lei Deng (10 shared papers)Jingwen Wang (2 shared papers)Cong Li (1 shared paper)Chong Chen (6 shared papers)Jie Lan (6 shared papers)Jingyao Chen (3 shared papers)
- Journals
- Frontiers in Oncology (2 papers)Radiotherapy and Oncology (2 papers)Cancer Cell (2 papers)Nature Communications (2 papers)Frontiers in Immunology (2 papers)
- Partner nations
- ChinaUnited StatesHungary
In The Last Decade
Feifei Na
46 papers receiving 1k citations
Peers
Comparison fields: 5 of 68
- Oncology 293
- Pulmonary and Respiratory Medicine 231
- Cancer Research 88
- Hepatology 45
- Immunology 85
Countries citing papers authored by Feifei Na
This map shows the geographic impact of Feifei Na's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Feifei Na with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Feifei Na more than expected).
Fields of papers citing papers by Feifei Na
This network shows the impact of papers produced by Feifei Na. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Feifei Na. The network helps show where Feifei Na may publish in the future.
Co-authors
The 25 scholars most cited alongside Feifei Na, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 49 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2014 | 130 | |
| 2 | 2017 | 105 | |
| 3 | 2022 | 99 | |
| 4 | 2020 | 84 | |
| 5 | 2022 | 61 | |
| 6 | 2022 | 53 | |
| 7 | 2020 | 40 | |
| 8 | 2015 | 38 | |
| 9 | 2024 | 34 | |
| 10 | 2017 | 30 | |
| 11 | 2013 | 28 | |
| 12 | 2023 | 26 | |
| 13 | 2023 | 26 | |
| 14 | 2013 | 24 | |
| 15 | 2015 | 23 | |
| 16 | 2022 | 23 | |
| 17 | 2022 | 18 | |
| 18 | 2022 | 16 | |
| 19 | 2023 | 16 | |
| 20 | 2018 | 15 |
About Feifei Na
Feifei Na is a scholar working on Oncology, Pulmonary and Respiratory Medicine, Cancer Research, Molecular Biology and Surgery, having authored 49 papers that have together received 1k indexed citations. Recurring topics across this work include Cancer Immunotherapy and Biomarkers (11 papers), Lung Cancer Research Studies (7 papers), Lung Cancer Diagnosis and Treatment (5 papers), Epigenetics and DNA Methylation (4 papers), Angiogenesis and VEGF in Cancer (4 papers), Lung Cancer Treatments and Mutations (3 papers), Cancer, Hypoxia, and Metabolism (3 papers) and Esophageal Cancer Research and Treatment (3 papers). The work is most often cited by research in Oncology (293 citations), Pulmonary and Respiratory Medicine (231 citations), Cancer Research (88 citations), Hepatology (45 citations) and Immunology (85 citations). Feifei Na has collaborated with scholars based in China, United States and Hungary. Frequent co-authors include Jianxin Xue, You Lü, Lei Deng, Jingwen Wang, Cong Li, Chong Chen, Jie Lan, Jingyao Chen, Xiawei Wei and Chunju Fang. Their work appears in journals such as Frontiers in Oncology, Radiotherapy and Oncology, Cancer Cell, Nature Communications and Frontiers in Immunology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.